•
•
•
•
•
•
•
The Irkutsk case explained, plus facts about a disease that still exists today
On 1 October 2026, a 28-year-old employee of the Irkutsk Anti-Plague Research Institute in Siberia died after being hospitalised on 29 September. Media widely reported the cause as pneumonic plague, but this has not been officially confirmed. Russia's health watchdog Rospotrebnadzor described it as "pneumonia of unknown etiology". Hospitals were placed under quarantine and nearly 200 people were put under observation. No symptomatic contacts had been identified as of early October, according to the UK Health Security Agency. The UK rates the risk to travellers as very low.
| Detail | Information |
|---|---|
| Patient | 28-year-old worker at the Irkutsk Anti-Plague Research Institute |
| Hospitalised | 29 September 2026 |
| Died | 1 October 2026 |
| Official description | "Pneumonia of unknown etiology" (Rospotrebnadzor) |
| Media reports | Suspected pneumonic plague (not officially confirmed) |
| Response | Hospital quarantine; ~200 people under observation |
The patient worked at a laboratory that studies plague, so a laboratory-acquired infection is one possibility being discussed. Investigators will need to confirm the diagnosis and the source.
Plague is caused by the bacterium *Yersinia pestis. It is best known for the Black Death of the 14th century, but it still exists in wild animal populations, mainly rodents and their fleas, in parts of Africa, Asia and the Americas*, including Russia, Mongolia, China and the western United States.
| Form | How it spreads | Key features |
|---|---|---|
| Bubonic | Bite of an infected flea | Painful swollen lymph nodes ("buboes"), fever |
| Septicaemic | Bacteria in the bloodstream | Severe illness, can follow bubonic plague |
| Pneumonic | Infected lungs; spreads person-to-person via respiratory droplets | Most dangerous form; rapid progression |
Symptoms usually appear 1–3 days after exposure:
Yes. Plague responds to common antibiotics such as streptomycin, gentamicin, doxycycline and ciprofloxacin, especially when treatment starts early. Untreated pneumonic plague is almost always fatal, so rapid diagnosis is critical. Close contacts are often given preventive antibiotics.
For the general public, no. Key reasons:
The case still matters for laboratory biosafety. Facilities working with dangerous pathogens must maintain strict safety standards.
As of early October 2026, one death was reported. It was suspected but not officially confirmed as pneumonic plague, and no secondary cases had been identified.
Yes, if untreated. With early antibiotic treatment, most patients survive.
Through respiratory droplets from an infected person or animal, usually requiring close contact.
There is no widely available plague vaccine for the general public. Prevention relies on avoiding rodents and fleas, protective measures for at-risk workers, and early antibiotics.
The Irkutsk case is a reminder that plague still exists. The main concerns are confirming the diagnosis, tracing contacts and reviewing laboratory safety. For the general public, the risk is very low, and plague remains treatable with antibiotics.
